Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 12,839 | 0 | 0 | 0 | 0 |
| Cost of Goods | 2,945 | N/A | N/A | N/A | N/A |
| Gross Profit | 9,894 | N/A | N/A | N/A | N/A |
| Operating Expenses | 31,176 | 55,903 | 33,366 | 37,482 | 22,814 |
| Operating Income | -20,337 | -55,903 | -33,366 | -37,482 | -22,814 |
| Interest Expense | 6,514 | 7,087 | 7,337 | 7,127 | 4,580 |
| Other Income | 2,307 | 6,398 | -2,726 | 28,078 | -27,244 |
| Pre-tax Income | -24,544 | -56,592 | -43,429 | -16,531 | -54,638 |
| Income Tax | -22 | -126 | -43 | -15 | 26 |
| Net Income Continuous | -24,522 | -56,466 | -43,386 | -16,516 | -54,664 |
| Net Income | $-24,522 | $-56,466 | $-43,386 | $-16,516 | $-54,664 |
| EPS Basic Total Ops | -13.23 | -50.40 | -47.36 | -18.08 | -118.72 |
| EPS Basic Continuous Ops | -13.23 | -50.39 | -47.37 | -18.10 | -118.69 |
| EPS Diluted Total Ops | -13.23 | -50.40 | -47.36 | -18.08 | -118.72 |
| EPS Diluted Continuous Ops | -13.23 | -50.39 | -47.37 | -18.10 | -118.69 |
| EPS Diluted Before Non-Recurring Items | -14.08 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-18,377 | $-53,961 | $-31,469 | $-35,691 | $-20,821 |